These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7688489)

  • 21. The concomitant use of dystrophin and utrophin/dystrophin related protein antibodies to reduce misdiagnosis of Duchenne/Becker muscular dystrophy.
    Khurana TS; Specht LA; Beggs AH; Tomé FM; Letureq F; Chevallay M; Chafey P; Kunkel LM
    Biochem Biophys Res Commun; 1997 Dec; 241(2):232-5. PubMed ID: 9425255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of CA repeat polymorphism in direct and indirect diagnosis of Duchenne and Becker muscular dystrophy].
    Musová Z; Mat'oska V; Krejcová S; Bóday A
    Cas Lek Cesk; 1997 Feb; 136(3):90-4. PubMed ID: 9221176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and carrier detection in a Duchenne muscular dystrophy family by multiplex polymerase chain reaction and microsatellite analysis.
    Jongpiputvanich S; Norapucsunton T; Mutirangura A
    J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S15-21. PubMed ID: 9071063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dystrophin and dystrophin-associated proteins. Their evaluation at the neuromuscular pathology laboratory].
    Navarro C
    Rev Neurol; 1999 Jan 16-31; 28(2):154-8. PubMed ID: 10101784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of dystrophin test for patients with various neuromuscular diseases--immunofluorescence and immunoblot analyses of dystrophin abnormalities].
    Ikeya K; Saito K; Yamauchi A; Kondo E; Komine S; Ikenaka H; Mishima M; Takahashi R; Harada T; Fukuyama Y
    No To Hattatsu; 1993 Jul; 25(4):328-34. PubMed ID: 8338694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal muscle biopsy: collaborative experience with varied indications.
    Evans MI; Hoffman EP; Cadrin C; Johnson MP; Quintero RA; Golbus MS
    Obstet Gynecol; 1994 Dec; 84(6):913-7. PubMed ID: 7970469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of the Duchenne muscular dystrophy gene in Spanish individuals: deletion detection and familial diagnosis.
    Patiño A; Narbona J; García-Delgado M
    Am J Med Genet; 1995 Nov; 59(2):182-7. PubMed ID: 8588583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of utrophin (dystrophin-related protein) and dystrophin-associated glycoproteins in muscles from patients with Duchenne muscular dystrophy.
    Mizuno Y; Yoshida M; Nonaka I; Hirai S; Ozawa E
    Muscle Nerve; 1994 Feb; 17(2):206-16. PubMed ID: 8114791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Monoclonal antibodies to dystrophin in biopsy diagnosis of Duchenne and Becker progressive muscular dystrophies].
    Lukás Z; Foretová L; Vojtísková M; Dráber P; Hájek J
    Cesk Patol; 1994 May; 30(2):37-42. PubMed ID: 8020113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
    Sundaram C; Vydehi B; Meena K; Murthy J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype.
    Nevo Y; Muntoni F; Sewry C; Legum C; Kutai M; Harel S; Dubowitz V
    Isr Med Assoc J; 2003 Feb; 5(2):94-7. PubMed ID: 12674656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated dystrophin analysis using immunocytochemical, biochemical and genetic techniques.
    Nicholson LV; Johnson MA; Davies KE
    Basic Appl Histochem; 1990; 34(3):169-75. PubMed ID: 1702616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal diagnosis of Duchenne muscular dystrophy by fetal muscle biopsy.
    Kuller JA; Hoffman EP; Fries MH; Golbus MS
    Hum Genet; 1992; 90(1-2):34-40. PubMed ID: 1427785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dystrophin expression in the developing conduction system of the human heart.
    Ginjaar IB; Virágh S; Markman MW; van Ommen GJ; Moorman AF
    Microsc Res Tech; 1995 Apr; 30(6):458-68. PubMed ID: 7599357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of truncated dystrophin in fetal DMD myotubes.
    Ginjaar IB; Bakker E; den Dunnen JT; Wessels A; van Paassen MM; Kloosterman MD; Zubrzycka-Gaarn EE; Fischbeck KH; Moorman AF; van Ommen GJ
    Adv Exp Med Biol; 1990; 280():17-23. PubMed ID: 2248137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal plasma carbonic anhydrase III in prenatal diagnosis of Duchenne muscular dystrophy.
    Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL; Rodeck C
    Am J Med Genet; 1985 Jan; 20(1):115-22. PubMed ID: 3918446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of dystrophin in fetuses at risk for Duchenne muscular dystrophy.
    Clerk A; Sewry CA; Dubowitz V; Strong PN
    J Neurol Sci; 1992 Aug; 111(1):82-91. PubMed ID: 1403002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased [32P]-phosphorylation of tryptic peptides of erythrocyte spectrin in Duchenne muscular dystrophy.
    Mabry ME; Roses AD
    Muscle Nerve; 1981; 4(6):489-93. PubMed ID: 7311988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.